Shopping Cart
- Remove All
Your shopping cart is currently empty
SRA880 is a non-peptide somatostatin sst(1) receptor antagonist which displays a significantly lower affinity for the other human recombinant somatostatin receptors ( pK(d)= 6.0) or a wide range of neurotransmitter receptors, except for the human dopamine D4 receptors. SRA880 positively modulates the release of endogenous SRIF, was found to synergize with imipramine in causing antidepressant-like effects in the tail suspension test.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | 3-6 months | |
| 50 mg | Inquiry | 3-6 months | |
| 100 mg | Inquiry | 3-6 months |
| Description | SRA880 is a non-peptide somatostatin sst(1) receptor antagonist which displays a significantly lower affinity for the other human recombinant somatostatin receptors ( pK(d)= 6.0) or a wide range of neurotransmitter receptors, except for the human dopamine D4 receptors. SRA880 positively modulates the release of endogenous SRIF, was found to synergize with imipramine in causing antidepressant-like effects in the tail suspension test. |
| Synonyms | SRA880, NVP-SRA-880, NVP-SRA880, NVPSRA880, NVP-SRA 880, NVP SRA880 |
| Molecular Weight | 568.62 |
| Formula | C29H36N4O8 |
| Cas No. | 573984-99-3 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.